Xinxiang Tuoxin Pharmaceutical Co., Ltd. (hereinafter referred to as the company) is a high-tech enterprise integrating the R & D, production and sales of chemical synthesis, biological fermentation nucleoside (acid) API and pharmaceutical intermediate. it has strong strength in the development and production of domestic nucleoside (acid) API and pharmaceutical intermediate products.
The company has the advantages of early start, large scale and full variety in the research and development of nucleoside (acid) APIs and pharmaceutical intermediates in China, and has formed a relatively complete ladder product chain from basic products to high-end products.
After nearly 20 years of development and accumulation, the company has improved the two core technologies of nucleoside production by chemical synthesis and biological fermentation.
On this basis, the company has established a high efficient catalytic synthesis technology platform, nucleoside fermentation technology platform and biotransformation semi-synthesis technology platform, and formed a series of nucleoside (acid) products, such as pyrimidine series, purine series, nucleotide series, nucleoside series, including citicoline sodium, ribavirin, inosine, acyclovir, cytosine, 5-fluorocytosine, cytidine and other raw materials and pharmaceutical intermediates.
It mainly covers the fields of antiviral, antineoplastic and nervous system drugs.
In terms of production management, the company has passed the ISO9001 quality management system certification, from product design and development, raw material procurement, process control to product sales to achieve full process control; in API production, the company has fully implemented GMP management, and a number of products have passed GMP certification.
The company actively carries on the certification and registration of all kinds of products at home and abroad, a number of API products have passed the DMF certification of India and Uzbekistan, and a number of pharmaceutical intermediate products have passed the official certification of Japan, the European Union and other countries and regions, such as EU REACH registration certificate, Japan PDMA certification, HALAL halal certification and KOSHER kosher certification.
As a technology-oriented high-tech enterprise, the company always takes "R & D innovation" as the core, and attaches great importance to the investment in product R & D and the improvement of its own comprehensive R & D strength.
The company has built "Henan postdoctoral R & D Base" and "National postdoctoral Research Workstation". It has been recognized as "National High-tech Industry demonstration Project", "the first backbone Enterprises of Henan High-tech characteristic Industrial Base", "Henan Enterprise Technology Center" and "Henan Nucleoside Engineering and Technology Research Center".
It has successively won the first prize for scientific and technological progress in Henan Province, the second prize for national scientific and technological progress and other major scientific and technological awards, and a number of products have been selected as "national key new products" and "National Torch Plan Project".
Tuoxin Pharmaceutical Co., Ltd. takes "focus on life science, care for human health" as its purpose, adheres to the enterprise spirit of "development, innovation, integrity and dedication", and looks forward to sincere cooperation with friends at home and abroad.